Low molecular weight heparin: the answer to adverse outcomes in obstetrics?

Martinelli I , Ruggenenti P , and Cetin I . Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood 2012; 119 (14): 3269–75.

Vries JIP , Van Pampus MG , and Hague WM . Low-molecular weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J Thromb Haemost 2012; 10: 64–72

Bates SA , Greer IA , and Middeldorp S . VTE, thrombophilia, antithrombotic therapy, and pregnancy. Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl. 2):e691S–736S

Robertson L , Wu O , and Langhorne P . Thrombophilia in pregnancy: a systematic review. Br J Haematol 2005; 132: 171–96

See http://clinicaltrials.gov/ct2/show/NCT00967382 (last checked 28 August 2012)